| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Abernethy Matt is a Chief Financial Officer at NEUROCRINE BIOSCIENCES INC. Recent SEC Form 4 filings include 0 buys and 13 sells.
Estimated insider holdings value: $5.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 13, 2025 | NBIX Neurocrine Biosciences Inc | Chief Financial Officer | Sale+OE | 2,558 | $116.86 | $298,923.22 | -3.5% | +1.6% | +6.2% | |
| Feb 10, 2025 | NBIX Neurocrine Biosciences Inc | Chief Financial Officer | Sale+OE | 980 | $118.27 | $115,908.52 | -2.8% | +1.4% | +15.9% | |
| Jan 31, 2025 | NBIX Neurocrine Biosciences Inc | Chief Financial Officer | Sale+OE | 1,283 | $152.87 | $196,135.80 | -3.8% | -29.8% | -10.4% | |
| Aug 13, 2024 | NBIX Neurocrine Biosciences Inc | Chief Financial Officer | Sale+OE | 14,100 | $150.38 | $2,120,346.72 | -30.9% | -15.6% | -12.7% | |
| Jul 16, 2024 | NBIX Neurocrine Biosciences Inc | Chief Financial Officer | Sale+OE | 900 | $150.04 | $135,036.99 | -2.8% | -21.0% | -9.5% | |
| May 15, 2024 | NBIX Neurocrine Biosciences Inc | Chief Financial Officer | Sale+OE | 30,000 | $137.95 | $4,138,435.50 | -32.2% | +6.1% | -15.3% | |
| Feb 13, 2024 | NBIX Neurocrine Biosciences Inc | Chief Financial Officer | Sell | 1,352 | $132.85 | $179,611.58 | -4.1% | +1.7% | -12.4% | |
| Feb 8, 2024 | NBIX Neurocrine Biosciences Inc | Chief Financial Officer | Sell | 2,260 | $138.73 | $313,529.61 | -3.6% | +3.4% | -8.8% | |
| Jan 31, 2024 | NBIX Neurocrine Biosciences Inc | Chief Financial Officer | Sell | 1,283 | $140.72 | $180,538.76 | -4.3% | -1.6% | +9.7% | |
| Aug 21, 2023 | NBIX Neurocrine Biosciences Inc | Chief Financial Officer | Sell | 2,132 | $107.39 | $228,958.46 | -7.3% | +1.0% | +38.1% |